These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Acquisition of Streptococcus pneumoniae in South African children vaccinated with 7-valent pneumococcal conjugate vaccine at 6, 14 and 40 weeks of age. Nunes MC; Jones SA; Groome MJ; Kuwanda L; Van Niekerk N; von Gottberg A; de Gouveia L; Adrian PV; Madhi SA Vaccine; 2015 Jan; 33(5):628-34. PubMed ID: 25541213 [TBL] [Abstract][Full Text] [Related]
5. [A case report of Streptococcus pneumoniae-induced hemolytic uremic syndrome: appropriate transfusional management by T-antigen determination]. Rinaudo-Gaujous M; Talagrand E; Verhoeven PO; Garraud O; Flourié F Ann Biol Clin (Paris); 2013; 71(2):215-8. PubMed ID: 23587591 [TBL] [Abstract][Full Text] [Related]
6. Streptococcus pneumoniae-associated hemolytic uremic syndrome among children in North America. Banerjee R; Hersh AL; Newland J; Beekmann SE; Polgreen PM; Bender J; Shaw J; Copelovitch L; Kaplan BS; Shah SS; Pediatr Infect Dis J; 2011 Sep; 30(9):736-9. PubMed ID: 21772230 [TBL] [Abstract][Full Text] [Related]
7. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway. Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490 [TBL] [Abstract][Full Text] [Related]
8. [Clinical analysis of hemolytic-uremic syndrome associated with Streptococcus pneumoniae serotype 3 infection in a child]. Meng SS; Yang Q; Han GQ; Yang JH; Zhang HL; Ye LP; Luo YC; Li CC Zhonghua Er Ke Za Zhi; 2013 Jul; 51(7):535-9. PubMed ID: 24267137 [TBL] [Abstract][Full Text] [Related]
9. Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era. Zuccotti G; Mameli C; Daprai L; Garlaschi ML; Dilillo D; Bedogni G; Faccini M; Gramegna M; Torresani E; ; Ballerini E; Benincaso A; Bonvissuto M; Bricalli D; Brioschi M; Calloni CS; Camiletti MI; Colella G; De Angelis L; Decarlis S; Di Nello F; Dozzi M; Galli E; Gandini V; Giuliani MG; Laviola F; Loda B; Macedoni M; Mazzucchi E; Metta MG; Moscatiello A; Nannini P; Petruzzi M; Picicco D; Picciotti M; Pisanelli S; Porta N; Ramponi G; Redaelli F; Rubini R; Sala N; Saitta V; Scelza G; Tiso RM; Tomasetto M; Torcoletti M; Travaini M; Valentini M; Vessia C Vaccine; 2014 Jan; 32(5):527-34. PubMed ID: 24342249 [TBL] [Abstract][Full Text] [Related]
14. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait. Mokaddas E; Albert MJ Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356 [TBL] [Abstract][Full Text] [Related]
15. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae. Dagan R Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():16-20. PubMed ID: 19366365 [TBL] [Abstract][Full Text] [Related]
16. [Invasive pneumococcal disease and hemolytic uremic syndrome]. Fàbregas Martori A; Moraga-Llop F; Nieto Rey J; Figueras Nadal C; Soler Palacín P; Roqueta Mas J An Pediatr (Barc); 2008 Mar; 68(3):269-72. PubMed ID: 18358139 [TBL] [Abstract][Full Text] [Related]
17. T-antigen activation for prediction of pneumococcus-induced hemolytic uremic syndrome and hemolytic anemia. Huang DT; Chi H; Lee HC; Chiu NC; Huang FY Pediatr Infect Dis J; 2006 Jul; 25(7):608-10. PubMed ID: 16804430 [TBL] [Abstract][Full Text] [Related]
18. Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolated from invasive infections after optional use of the 7-valent conjugate vaccine in Korea, 2006-2010. Cho EY; Lee H; Choi EH; Kim YJ; Eun BW; Cho YK; Kim YK; Jo DS; Lee HS; Lee J; Kim MN; Kim DS; Lee HJ Diagn Microbiol Infect Dis; 2014 Apr; 78(4):481-6. PubMed ID: 24529940 [TBL] [Abstract][Full Text] [Related]
19. Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage. Watson M; Bayley K; Bell JM; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Roche P; Smith HV; Stewart MG; Stylianopoulos J; Turnidge J Commun Dis Intell Q Rep; 2003; 27(4):478-87. PubMed ID: 15508501 [TBL] [Abstract][Full Text] [Related]
20. Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged ≥50 years with community-acquired pneumonia. Sherwin RL; Gray S; Alexander R; McGovern PC; Graepel J; Pride MW; Purdy J; Paradiso P; File TM J Infect Dis; 2013 Dec; 208(11):1813-20. PubMed ID: 24092845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]